• "Masks" of CNS demyelinating diseases. Primary lymphoma
• A case report of primary central nervous system lymphoma with immune deficiency/disorder setting diagnosed by cerebrospinal fluid cytology
• A rare development of classical Hodgkin lymphoma in the head and neck region: Case report and review of the literature
• Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial
• Applications of cell therapy in the treatment of virus-associated cancers
• Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia
• Association Between Immunoparesis and Treatment Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
• Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation
• Atypical Cutaneous Manifestation of Mycosis Fungoides: A Case Report
• Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma
• Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
• Brain stem angioleiomyoma mimicking meningioma: a case report
• Case report: An intriguing case of Philadelphia chromosome-positive acute lymphoblastic leukemia recurrence
• CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient's age, and tumor types
• Clinical relevance of brain MRI changes in primary central nervous system lymphoma after high-dose-chemotherapy and autologous stem cell transplantation
• Clinicopathological Profile of Primary Extra Nodal Lymphoma from a Tertiary Care Center in South India
• Comparison Between Endobronchial Ultrasound-Guided Transbronchial Node Biopsy and Transbronchial Needle Aspiration: A Meta-Analysis
• Concurrent identification of follicular lymphoma and papillary thyroid carcinoma
• Conservative treatment in orthopedic oncology surgery ?
• Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study
• Deep sequencing as a diagnostic tool in patients with suspected primary vitreoretinal lymphoma
• Dermatoscopy and Histology of Primary Cutaneous Aggressive Epidermotropic CD8+ T-Cell Lymphoma
• Dermoscopic features of primary cutaneous extranodal natural killer (NK)/T-cell lymphoma
• DETECTION OF CIRCULATING TUMOR DNA FOR DISEASE MONITORING IN PATIENTS WITH PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA, LEG TYPE
• Diffuse large B-cell lymphoma in the C8 root mimicking a schwannoma: illustrative case
• Discovery of a small-molecule inhibitor of KSHV lytic replication from the MMV Pandemic Response Box
• Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals
• Efficacy analysis of <em>ALK</em> inhibitors for treating lung squamous carcinoma patients harboring <em>ALK</em> rearrangement
• Efficacy of Combination of Antiviral Therapy With Neutralizing Monoclonal Antibodies for Recurrent Persistent SARS-CoV-2 Pneumonia in Patients With Lymphoma
• Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword
• Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic Significance
• Evolving consolidation patterns and outcomes for a large cohort of primary CNS lymphoma patients
• Exploring the Cytotoxic and Anticancer Potential of Naringin on Oral Cancer Cell Line
• Factors influencing timely diagnosis in neurolymphomatosis
• Harnessing Deep Learning for Accurate Pathological Assessment of Brain Tumor Cell Types
• Hematological malignancy-associated pyoderma gangrenosum: evaluating the magnitude of the association
• Hematological Second Primary Malignancy in Pediatric Retinoblastoma: A Case Report and Systematic Review
• High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial
• Histone deacetylase inhibitor and PD-1 blockade synergistically inhibit B-cell lymphoma progression in mice model by promoting T-cell infiltration and apoptosis
• Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties
• Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseases
• Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes
• Intestinal Perforation in a Case of Peripheral T Cell Lymphoma after Initiation of Chemotherapy
• Isolated Monoclonal T-Cell Receptor Gene Rearrangement in a Lung Adenocarcinoma Harboring <em>MET</em> Exon 14 Skipping: Diagnostic Pitfall
• Long-term remission with temozolomide for AIDS-related primary central nervous system lymphoma
• Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature
• Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors-A Literature Review
• Modified SMILE (mSMILE) is active in the treatment of pediatric Epstein-Barr virus-associated natural killer/T-cell lymphoma: a single center experience, case series
• Multiple primary diffuse large B-cell lymphoma masquerading as meningioma
• Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma
• Navigating Diagnostic and Therapeutic Challenges in Primary Cutaneous Gamma/Delta T-Cell Lymphoma: A Case Study of Fatal Outcomes Within Two Months
• Nivolumab in Relapsed or Refractory Primary CNS Lymphoma: Multicenter, Retrospective Study
• Non-Breast Implantable Medical Devices and Associated Malignancies: A Systematic Review
• Non-small Cell Lung Cancer with Metachronous Mutations of EGFR and ALK Genes: 
A Case Report and Literature Review
• Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
• Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study
• PD-L1 expression from surgically resected lung tumors predictive of early progression in patients previously treated with targeted therapy for initially unresectable non-small cell lung cancer
• Pediatric therapy-related hematologic neoplasms show enrichment for <em>KMT2A</em> rearrangement and lymphoblastic phenotype
• Peripheral lymphadenopathy of unknown origin in adults: a diagnostic approach emphasizing the malignancy hypothesis
• Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial
• Pomalidomide Use and Kidney Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study
• Predicting prognosis outcomes of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment using lipidomics
• Primary Bladder Lymphoma with Extravesical Extension: A Case Report and Literature Review on Prognosis and Clinical Characteristics
• Primary Central Nervous System Lymphoma Presenting With Cauda Equina Syndrome and Bilateral Third Nerve Palsies
• Primary Cutaneous Spindle Cell B-Cell Follicle Center Lymphoma Presenting as Long-Standing Plaque of Cicatricial Alopecia: A Case Report With a Comprehensive Review of the Literature
• Primary intestinal T-cell and natural killer-cell lymphomas: Clinicopathologic and prognostic features of 79 cases in South China
• Primary pulmonary mucosa-associated lymphoid tissue lymphoma with extensive lung involvement and negative autoimmune and inflammatory background: A case report and literature review
• Primary Rectal Syphilis Mimicking Lymphoma: A Case Report and Literature Review
• Primary Sjogren's syndrome without ocular manifestation: a case report
• Primary Vitreoretinal Lymphoma Presenting Solely with Asymptomatic Peripheral Drusenoid Lesions
• Radiolabeled Somatostatin Analogs for Cancer Imaging
• Rare primary colonic T cell lymphoma with curative resection by endoscopic submucosal dissection: A case report
• Recurrent Hypoglycemia in a 67-Year-Old Woman with CD5- Positive Diffuse Large B-Cell Lymphoma
• Rethinking the role of surgical resection in the management of primary pituitary lymphoma
• Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine
• Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial
• Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
• Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
• Serial regression of primary gastric diffuse large B cell lymphoma after Helicobacter pylori eradication therapy: A case report
• SILICONE FINE-NEEDLE ASPIRATION RETINAL BIOPSY: A Novel Surgical Technique for Vitreoretinal Lymphoma
• Simultaneous merkel cell carcinoma and acute myeloid leukaemia: A diagnostic challenge
• Simultaneous occurrence of papillary thyroid carcinoma, medullary thyroid carcinoma, and lymphoma: A case report
• Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes
• Spectrum of imaging findings of primary bone lymphoma in pediatric patients
• SPH7854, a gut-limited RORγt antagonist, ameliorates TNBS-induced experimental colitis in rat
• Standardization of CD30 immunohistochemistry staining among three automated immunostaining platforms
• Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis
• Synchronous Invasive Ductal Carcinoma of Breast and Diffuse Large B-cell Lymphoma: A Case Report
• Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial
• Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors
• Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study
• The Baseline Pan-Immune-Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma
• The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2^nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study
• The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain
• The NOTCH1 and miR-34a signaling network is affected by <em>TP53</em> alterations in CLL
• The Prognostic Significance of Pontine-White Matter Score in Primary Central Nervous System Lymphoma Patients
• Towards personalized and rational use of immunoglobulins amid expanding indications and shortages
• Two-year Outcomes of Ultra-low-dose Radiotherapy in the Treatment of Ocular Adnexal B-cell Lymphomas
• Ultrasound scanning in diagnosing primary thyroid lymphoma
• Understanding Myeloma-Related Information Needs and Communication Preferences Within Black American Communities: An Exploratory Study